Status:
TERMINATED
Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease
Lead Sponsor:
Medivation, Inc.
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
50+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the safety and efficacy of Dimebon in combination with donepezil (Aricept) in the treatment of Alzheimer's disease.
Eligibility Criteria
Inclusion
- Alzheimer's disease
- On donepezil (Aricept)
- Caregiver who cares for the patient at least 5 days per week
Exclusion
- Unstable medical illnesses or significant hepatic or renal disease
- Other primary psychiatric or neurological disorders
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00704782
Start Date
April 1 2008
End Date
August 1 2010
Last Update
December 10 2015
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Xenoscience, Inc.
Phoenix, Arizona, United States, 85004
2
Banner Alzheimer's Institute
Phoenix, Arizona, United States, 85006
3
Barrow Neurological Institute
Phoenix, Arizona, United States, 85013
4
Sun Health Research Institute
Sun City, Arizona, United States, 85351